• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Relmada rails against depression data both 'implausible' and...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Dec 08, 2022 at 10:22: AM
via Relmada Therapeutics’ REL-1017 has failed another phase 3 depression clinical trial. And, like last time, the biotech has blamed everything but the drug candidate, pinning the failures on “a limited number of high enrolling sites with unplausible placebo response.”

article source
 




Top Bottom
Back
Quote